Conor Medsystems, Biotronik DES Would Compete With Established Players
This article was originally published in The Gray Sheet
Executive Summary
Conor Medsystems expects technological characteristics - not price - will successfully position its CoStar drug-eluting stent against offerings from Johnson & Johnson and Boston Scientific